Zhengye Biotechnology Holding Limited (ZYBT)
NASDAQ: ZYBT · Real-Time Price · USD
1.730
+0.580 (50.45%)
At close: Oct 9, 2026, 4:00 PM EDT
1.780
+0.050 (2.89%)
After-hours: Oct 9, 2026, 7:59 PM EDT
ZYBT Market Cap
ZYBT has a market cap or net worth of $81.99 million as of October 9, 2026. It is the 29,805th most valuable company in the world and the 4,608th biggest in the United States. Its market cap has decreased by 43.83% in one year.
Market Cap
81.99M
Enterprise Value
85.30M
1-Year Change
-43.83%
Global Rank
Country Rank
#4,608 United States
Category
ChartMarket Cap Chart
Since the IPO on January 7, 2025, ZYBT's market cap has decreased from $188.67M to $81.99M, a decrease of -56.54%. That is a compound annual growth rate of -37.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 81.99M | 50.43% |
| Dec 31, 2025 | 54.50M | -71.11% |
| Jan 7, 2025 | 188.67M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cumberland Pharmaceuticals | 106.68M |
| Citius Oncology | 89.90M |
| InterCure | 65.04M |
| Talphera | 57.62M |
| SCYNEXIS | 48.16M |
| Incannex Healthcare | 39.77M |
| Rockwell Medical | 30.83M |
| China Pharma Holdings | 27.58M |